Dolcas Biotech — 1 certified H-1B filings (FY2022)

1
Filings · FY2022
$80k
Median base · FY2022
QC Associate
Top role · 1 all-time
NJ
Top state · 1 all-time
FY

Dolcas Biotech filed 1 certified H-1B LCAs in FY2022, with a median base salary of $80k and the middle 50% of offers between $80k and $80k. Across all years it has 1 certified filings since FY2022, most often for QC Associate in New Jersey.

How much does Dolcas Biotech pay H-1B workers?

Certified base salary by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $80k median in FY2022. Base pay only — hover a year for its figures.

$70k$80k$90k$100k’22

How has Dolcas Biotech's H-1B hiring changed by year?

1 certified filings on record (FY2022).

Dolcas Biotech certified H-1B filings and base salary by fiscal year
Fiscal yearFilingsvs prior FYMedian base
FY20221—$80k

Which wage levels does Dolcas Biotech file?

DOL prevailing-wage levels I–IV approximate experience tiers (I = entry, IV = fully competent). 100% of Dolcas Biotech's filings sit at Level III–IV. A heavy I–II skew reads as entry-level or contractor-style hiring; a heavy IV skew as senior in-house roles — and higher levels earn more lottery entries.

Share of 1 filings with a wage level · all years

100%
  • Level IV100.0%1

What jobs does Dolcas Biotech sponsor for H-1B?

The most-filed job titles across all years (DOL titles, employer pay-grade codes stripped), with base-salary percentiles.

Dolcas Biotech most-sponsored H-1B job titles with base-salary percentiles
Job titleFilingsMedian base
QC Associate1$80k

Where does Dolcas Biotech hire H-1B workers?

Worksite states on the certified filings, all years. Deeper pink = more filings; hover a state for its figures.

11Certified filings (log scale)
Dolcas Biotech H-1B worksite states
StateFilingsMedian base
NJ1$80k

What has Dolcas Biotech filed recently?

Every certified LCA on record for Dolcas Biotech: job title, worksite, prevailing-wage level and the offered base salary.

Dolcas Biotech recent certified H-1B LCA filings
FYJob titleBase salary
2022QC Associate$80,018

Common questions about Dolcas Biotech's H-1B filings

How much does Dolcas Biotech pay H-1B workers?
Dolcas Biotech's median certified H-1B base salary is $80k (FY2022), from 1 filings. See the full salary distribution and percentiles above.
How many H-1B workers does Dolcas Biotech sponsor?
Dolcas Biotech has 1 certified H-1B Labor Condition Applications on record (FY2022).
What jobs does Dolcas Biotech sponsor for H-1B?
Dolcas Biotech's most-sponsored H-1B roles include QC Associate.
Where does Dolcas Biotech hire H-1B workers?
Dolcas Biotech's top H-1B worksite states are NJ.
Does a certified LCA mean an H-1B visa was approved?
No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
What salary do these figures show?
The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
What do prevailing-wage levels I–IV mean?
The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.

Keep exploring

Browse all sponsors →

Calculate your H-1B lottery odds →orCheck out the insights →

Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2022). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →